S&P 500 Futures
(0.07%) 5 520.75 points
Dow Jones Futures
(0.13%) 39 894 points
Nasdaq Futures
(0.16%) 19 782 points
Oil
(-0.07%) $81.57
Gas
(0.68%) $2.83
Gold
(-0.27%) $2 338.10
Silver
(0.12%) $29.56
Platinum
(0.48%) $1 006.60
USD/EUR
(0.04%) $0.932
USD/NOK
(-0.06%) $10.53
USD/GBP
(0.01%) $0.788
USD/RUB
(-0.85%) $87.25

Aktualne aktualizacje dla Infinity Pharmaceuticals [INFI]

Giełda: NASDAQ Sektor: Healthcare Branża: Biotechnology
Ostatnio aktualizowano29 rugs. 2023 @ 22:59

-52.38% $ 0.00800

Live Chart Being Loaded With Signals

Commentary (29 rugs. 2023 @ 22:59):
Profile picture for Infinity Pharmaceuticals Inc

Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the treatment of solid tumors...

Stats
Dzisiejszy wolumen 2.48M
Średni wolumen 3.98M
Kapitalizacja rynkowa 726 089
EPS $-0.110 ( Q2 | 2023-08-10 )
Następna data zysków ( $0 ) 2024-08-08
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.0182
(Sector) 42.63
(Industry) 24.32
ATR14 $0.00900 (230.77%)
AADI 3.55%
ABCL -3.79%
ABCM 0.04%
ABEO -5.02%
ABIO -0.29%
ABOS -3.03%
ABSI 0.66%
ABUS 0.66%
ABVX 2.61%
ACAD 3.79%
ACER -17.95%
ACET 9.49%
ACGN 1.29%
ACHL 0.22%
ACHV -4.83%
ACIU 2.47%
ACLX -0.09%
ACRV -5.30%
ACST -0.31%
ACXP -2.15%
ADAG 0.69%
ADAP -1.06%
ADGI 0.87%
ADIL 2.68%
ADMA 0.09%
ADPT 1.54%
ADTX -2.08%
ADVM 1.63%
ADXN -5.75%
AEON -7.34%
AEZS -1.10%
AFMD 1.02%
AGEN 4.60%
AGIO 0.02%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA -0.69%
AKRO 2.80%
AKTX -1.08%
AKUS 0.00%
ALBO 0.00%
ALDX -5.46%
ALEC 0.44%
ALGS -4.88%
ALKS -1.28%
ALLK 8.11%
ALLO 2.35%
ALLR -28.40%
ALNA 3.16%
ALNY 34.52%
ALPN 0.02%
ALPX 0.00%
ALRN -1.60%
ALT 11.39%
ALVR 4.92%
ALXN 0.00%
ALXO -0.15%
ALZN -7.26%
AMRN 2.72%
AMTI -3.13%
ANAB 0.21%
ANEB -1.49%
ANGN 0.00%
ANIX -0.79%
ANL 0.29%
ANNX -4.22%
ANPC -3.15%
APGE 2.63%
APGN 8.48%
APGNW 30.65%
APLM 9.95%
APLS 0.92%
APLT 1.76%
APM 1.73%
APOP 0.38%
APRE 3.24%
APTO -2.37%
APTX 3.17%
APVO 1.15%
ARAV -13.39%
ARCT -0.44%
ARDS 2.49%
ARDX 1.46%
ARGX 11.69%
ARNA 0.00%
ARPO -0.90%
ARQT 4.59%
ARTL -2.71%
ARTLW 0.00%
ARVN -0.99%
ARWR 6.82%
ASLN -2.99%
ASMB 0.38%
ASND 1.20%
ATAI 4.48%
ATHA 1.28%
ATHE 2.27%
ATHX -33.50%
ATNF 2.05%
ATOS -5.31%
ATRA 0.67%
ATXI 9.52%
ATXS -2.65%
AUPH 2.35%
AURA -1.25%
AUTL -2.87%
AVBP -0.78%
AVEO 0.00%
AVIR 1.45%
AVRO -1.41%
AVTE -3.85%
AVTX 2.99%
AVXL 3.19%
AXLA 0.00%
AXSM 2.76%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO -15.94%
BCAB 3.31%
BCDA -5.67%
BCDAW -39.75%
BCEL 0.00%
BCLI 2.70%
BCRX -2.34%
BCTX -7.44%
BCTXW -18.26%
BCYC 0.10%
BDRX -15.63%
BDTX 0.83%
BEAM 8.24%
BFRA -2.91%
BGNE 1.95%
BIOR 1.50%
BIVI 0.96%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX 3.39%
BLTE 0.27%
BLU 0.03%
BLUE 13.45%
BMEA 5.51%
BMRN 1.62%
BNOX 2.99%
BNTC 4.80%
BNTX 2.33%
BOLD 13.42%
BOLT -1.45%
BPMC 1.79%
BPTH 0.88%
BPTS -13.47%
BRNS 0.00%
BRTX 1.72%
BTAI 4.39%
BTTX 0.00%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI -1.78%
CABA -1.53%
CADL 1.82%
CALA 0.00%
CALC -1.87%
CALT 1.83%
CAPR 1.91%
CARA 22.71%
CARM 9.80%
CASI 7.65%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS -4.40%
CCCC 11.08%
CCXI 0.00%
CDAK 0.00%
CDIO -0.17%
CDIOW 36.86%
CDMO -4.38%
CDMOP 0.04%
CDT -7.05%
CDTTW -23.91%
CDTX -2.84%
CDXC -6.59%
CDXS 2.04%
CELC 4.58%
CELU 0.66%
CELUW 11.18%
CERC -1.68%
CERE -0.55%
CERO 2.09%
CEROW -22.90%
CFRX -27.95%
CGEM -0.34%
CGEN -5.08%
CGON 1.50%
CGTX -2.63%
CHMA -6.00%
CHRS -2.40%
CINC 0.00%
CING 4.73%
CINGW 73.79%
CKPT 15.56%
CLBS -16.75%
CLDX 2.55%
CLGN 6.22%
CLLS 1.06%
CLNN -3.46%
CLNNW -33.25%
CLRB 0.00%
CLSD 0.00%
CLSN -0.68%
CLVS 0.00%
CMMB 8.57%
CMND -7.59%
CMPI 0.00%
CMPX 0.91%
CMRA 0.00%
CMRAW 33.33%
CMRX 1.85%
CNCE 0.00%
CNSP 12.63%
CNST 0.00%
CNTA -2.31%
CNTB -6.25%
CNTX 0.93%
COCP -1.88%
COEPW 0.00%
COGT 1.14%
CORT 1.83%
COYA -2.48%
CPRX -1.28%
CRBP 2.42%
CRBU 8.72%
CRDF -3.67%
CRGX 4.50%
CRIS 3.02%
CRNX 0.18%
CRSP 3.02%
CRTX 2.63%
CRVO 0.40%
CRVS 2.81%
CSBR -1.20%
CTCX -7.84%
CTIC 0.06%
CTMX 3.10%
CTNM 3.23%
CTXR 4.68%
CUE 8.89%
CVAC 6.44%
CVKD 6.24%
CWBR 0.00%
CYAD -12.96%
CYCC -5.01%
CYCCP 4.03%
CYCN 6.69%
CYT -2.27%
CYTK 0.71%
CYTO 2.61%
DARE 1.96%
DAWN -1.10%
DBTX -0.81%
DBVT -1.80%
DFFN 10.28%
DICE 0.06%
DMAC 2.78%
DNLI 1.24%
DNTH -0.04%
DOMH -2.63%
DRMA 12.50%
DRMAW -1.25%
DRNA 0.00%
DRTS 1.62%
DRTSW 0.00%
DRUG -3.77%
DSGN -0.59%
DTIL 0.85%
DYAI -9.66%
EARS -1.77%
EDIT -0.59%
EDSA -0.11%
EFTR -75.81%
EFTRW -96.33%
EIGR -9.21%
ELAB 0.86%
ELDN -4.40%
ELEV -4.30%
ELOX 0.00%
ELTX 6.89%
ELVN 1.87%
ELYM -8.69%
ENGN -9.67%
ENGNW -7.87%
ENLV 3.68%
ENOB 1.79%
ENSC 4.98%
ENTA 2.43%
ENTO -2.13%
ENTX 1.98%
ENVB 9.19%
EPIX -1.02%
EPRX 0.57%
EPZM 0.00%
EQ 2.52%
EQRX -2.09%
EQRXW 0.00%
ERAS 2.37%
ERNA -4.64%
ERYP 1.30%
ESLA -0.50%
ESLAW 0.00%
ETNB -0.82%
ETON -0.60%
ETTX 0.00%
EVAX -5.28%
EVGN -2.18%
EVLO 0.00%
EWTX -1.99%
EXAI -2.78%
EXEL 0.54%
EYEG 0.11%
EYEN 2.28%
EYPT 0.59%
FATE 2.13%
FBIO -3.95%
FBIOP 0.59%
FBLG 5.49%
FBRX 0.27%
FDMT 1.35%
FENC -1.09%
FGEN 6.19%
FHTX 0.38%
FIXX 0.77%
FMTX 0.00%
FNCH -6.77%
FOLD -0.89%
FREQ 4.76%
FRLN 0.15%
FRTX -4.51%
FSTX 0.00%
FTRE -0.65%
FULC -5.09%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT -8.97%
GANX 0.00%
GBIO 1.45%
GBT 0.01%
GDTC 5.61%
GERN -1.29%
GHRS 0.42%
GLMD -1.83%
GLPG 1.67%
GLSI -4.73%
GLTO 5.51%
GLUE 4.96%
GLYC 3.61%
GMAB -0.81%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT 1.29%
GNLX 10.68%
GNPX 0.00%
GNTA 7.74%
GOSS 27.09%
GOVX 30.04%
GOVXW 49.24%
GPCR -4.15%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS 4.76%
GRTX 40.48%
GTHX -10.48%
GUTS 5.77%
GXGXW 41.67%
GYRE -3.28%
HALO 0.99%
HARP 0.09%
HCWB 10.69%
HEPA 5.42%
HGEN -84.62%
HILS 5.66%
HLVX 2.75%
HOOK -1.07%
HOTH 0.67%
HOWL -9.38%
HRMY -0.10%
HRTX -1.55%
HSTO 0.00%
HUMA -1.35%
HUMAW 5.19%
IBRX 1.10%
ICCC -0.22%
ICPT 0.21%
ICU 10.12%
ICUCW 14.68%
ICVX -0.91%
IDRA -23.04%
IDYA 0.03%
IFRX 8.44%
IGMS 0.00%
IKNA -2.33%
IKT -5.00%
IMAB 2.38%
IMCR -0.28%
IMGN 0.02%
IMGO 0.00%
IMMP -2.92%
IMMX 11.76%
IMNM -4.02%
IMNN -4.46%
IMPL -27.27%
IMRA 15.96%
IMRN 12.11%
IMRX 4.20%
IMTX -1.37%
IMTXW -14.50%
IMUX -0.90%
IMV 0.00%
IMVT 0.18%
INAB -0.84%
INBX 2.18%
INCY 0.84%
INDP -1.33%
INFI -52.38%
INKT -1.62%
INM 9.72%
INMB 1.62%
INO -1.61%
INSM 0.65%
INTS 4.74%
INVA 0.63%
INZY 0.67%
IOBT 0.00%
IONS 6.81%
IOVA 1.87%
IPA -1.92%
IPHA -5.16%
IPSC -6.29%
IRON 1.81%
ISEE 0.38%
ITOS 0.61%
ITRM -5.65%
IVA -0.71%
IVVD 2.42%
JAGX -3.32%
JANX 5.52%
JAZZ 1.72%
JNCE 0.00%
JSPR 1.72%
JSPRW 4.71%
JUNS 0.00%
JUNSW 0.00%
KA 13.13%
KALV -0.17%
KDNY 0.22%
KMPH -0.34%
KNSA 1.40%
KNTE -0.38%
KOD 3.41%
KPRX 9.68%
KPTI 12.76%
KRBP -0.40%
KRON -6.48%
KROS 0.09%
KRRO -0.76%
KRTX 0.03%
KRYS 1.97%
KTRA 6.15%
KTTA 4.85%
KTTAW -5.17%
KURA 0.67%
KYMR -1.69%
KYTX 2.07%
KZIA -15.51%
KZR 1.12%
LABP 0.57%
LBPH 0.05%
LBPS 0.00%
LBPSW 14.81%
LEGN 1.13%
LENZ -1.52%
LEXX -1.49%
LEXXW -0.19%
LGND 0.72%
LGNDV 0.00%
LGVN -12.73%
LIAN -8.28%
LIFE 2.70%
LIPO 10.88%
LIXT -1.57%
LIXTW 0.00%
LJPC -0.32%
LMNL 0.12%
LOGC 1.27%
LPCN 3.56%
LPTX -2.08%
LQDA 3.28%
LRMR -10.33%
LSTA -3.26%
LTRN -5.78%
LUMO 1.79%
LVTX 0.27%
LXEO 4.94%
LXRX -2.16%
LYEL 3.41%
LYRA -2.78%
MACK 0.10%
MBIO 2.70%
MBRX -3.48%
MCRB -2.19%
MDGL 2.00%
MDNA -13.16%
MDWD 7.88%
MDXG -1.02%
MEIP -2.80%
MESO -3.28%
MGNX 2.97%
MGTA -7.74%
MGTX -3.18%
MGX 0.56%
MIRM 8.74%
MIRO 0.59%
MIST 0.72%
MITO 0.00%
MLEC -5.36%
MLECW 90.24%
MLND -5.36%
MLTX 0.73%
MLYS 4.90%
MNKD 6.26%
MNMD 0.27%
MNOV 0.00%
MNPR 15.76%
MOLN -25.10%
MOR -0.11%
MORF 10.26%
MREO -5.53%
MRKR 9.03%
MRNA 2.70%
MRNS 3.01%
MRSN 3.76%
MRTX -0.17%
MRUS 3.77%
MRVI -2.35%
MTCR -1.29%
MTEM -4.59%
MTP -18.50%
MURA -0.62%
MYMD -4.12%
NAMS 8.93%
NAMSW 26.87%
NAUT -8.57%
NBRV 0.71%
NBSE -1.56%
NBTX 4.81%
NCNA -0.34%
NERV -5.52%
NEXI -2.44%
NGM -1.28%
NGNE 2.39%
NKGN 0.00%
NKGNW 8.00%
NKTR 0.86%
NKTX 1.82%
NLSP -5.16%
NLSPW 28.30%
NMRA 0.00%
NMTR -42.97%
NOVN -24.84%
NRBO 0.49%
NRIX -1.27%
NRSN -3.99%
NRSNW 0.00%
NRXP 0.75%
NRXPW 0.00%
NRXS -0.78%
NTBL 0.36%
NTEC -12.45%
NTHI 0.00%
NTLA 3.22%
NTRBW 0.00%
NUVL 1.72%
NVAX 0.14%
NVCT 2.13%
NVIV -34.28%
NXTC 3.70%
NYMX -0.05%
OABI 1.75%
OABIW -3.65%
OBIO 9.02%
OBSV 0.00%
OCEA 7.75%
OCGN -5.26%
OCS 1.37%
OCUL 4.48%
OCUP 1.27%
ODT -4.27%
OKYO -1.63%
OLMA 2.15%
OMER 2.90%
OMGA -0.41%
ONCO -6.85%
ONCR -3.08%
ONCS 31.87%
ONCT -1.85%
ONCY 0.00%
ONTX -0.47%
ONVO -2.28%
OPNT 0.00%
OPT -4.93%
ORGS -3.25%
ORIC -1.11%
ORMP -3.04%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -2.62%
OVID 1.28%
OYST 0.00%
PALI -3.95%
PASG 0.00%
PBLA -4.76%
PBM -4.74%
PBYI -2.34%
PCSA 0.51%
PCVX 1.12%
PDSB 8.33%
PEPG 4.57%
PGEN 4.55%
PHAR 13.76%
PHAS 0.00%
PHAT -2.26%
PHIO 3.65%
PHIOW 36.47%
PHVS -4.62%
PHXM -5.20%
PIRS -5.56%
PKBO 0.00%
PKBOW 999 900.00%
PLRX 3.28%
PLUR -0.44%
PMN -0.63%
PMVP 4.64%
PNT 0.16%
PPBT 5.78%
PRAX -2.61%
PRDS 0.93%
PRLD 2.88%
PROG -3.47%
PROK -7.60%
PRQR -3.51%
PRTA 0.56%
PRTC -6.90%
PRTG -0.04%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -11.11%
PSTX -1.08%
PTCT -2.05%
PTE -0.82%
PTGX -0.78%
PTIXW -5.10%
PULM -2.53%
PXMD 0.00%
PYPD -1.97%
PYXS -5.34%
QLGN -8.10%
QNCX 0.71%
QNRX 1.44%
QSI 0.84%
QSIAW 1.20%
QTTB -0.71%
QURE -1.09%
RAIN -1.63%
RANI -0.96%
RAPT 3.18%
RARE -0.45%
RCKT 7.03%
REGN 1.02%
RENB 1.27%
REPL 3.06%
RETA 0.02%
REUN -0.89%
REVB 13.74%
REVBU 3.46%
REVBW 50.29%
RGLS -18.33%
RGNX 6.41%
RIGL 0.65%
RLAY -0.58%
RLMD -0.99%
RLYB 5.48%
RNA 1.69%
RNAC 1.05%
RNAZ 5.27%
RNXT 4.09%
ROIV 2.06%
ROIVW 4.56%
RPHM 0.00%
RPRX 0.74%
RPTX 0.28%
RUBY 2.70%
RVLP -32.05%
RVMD 0.76%
RVMDW 17.51%
RVNC -3.38%
RVPH 2.40%
RVPHW 1.92%
RXDX 0.09%
RXRX 5.54%
RYTM 1.58%
RYZB 0.02%
RZLT 7.85%
SABS 4.23%
SABSW -35.81%
SAGE 3.86%
SANA 0.54%
SAVA -1.10%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI -6.67%
SCPH 1.24%
SCPS 0.00%
SEEL -2.49%
SEER 1.76%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO 5.62%
SGMT 6.87%
SGTX -2.56%
SIOX 22.63%
SLDB 2.48%
SLGL 0.59%
SLN 3.61%
SLNO -2.60%
SLRX -3.97%
SLS -0.82%
SMMT 0.88%
SNDX -1.25%
SNGX -2.31%
SNPX 5.67%
SONN -6.53%
SPPI -0.49%
SPRB 5.39%
SPRC -2.42%
SPRO -2.92%
SRNE 15.79%
SRPT 1.95%
SRRA 0.00%
SRRK -0.47%
SRZN 5.26%
STAB 0.00%
STOK 0.70%
STRO -4.95%
STSA 0.00%
STTK -9.50%
SURF -0.93%
SVRA -5.67%
SWTX -0.17%
SYBX 2.01%
SYRS 4.12%
TALS -0.73%
TARA -1.33%
TARS 1.36%
TBPH 0.23%
TCBP -8.11%
TCDA 0.00%
TCON -1.60%
TCRR 0.00%
TCRT -3.84%
TCRX 2.92%
TECH 1.13%
TENX 9.03%
TERN 4.01%
TFFP 9.20%
TGTX 4.31%
THRX 0.12%
TIL -3.68%
TLC 0.00%
TLSA 14.49%
TNGX 0.50%
TNXP -8.46%
TNYA -0.96%
TPST 2.96%
TRDA -4.11%
TRVI -2.22%
TRVN -13.99%
TSHA -10.14%
TSVT 3.76%
TTNP -14.84%
TVTX 6.57%
TYRA 0.35%
UBX 0.36%
UNCY 7.44%
URGN 5.81%
UTHR 0.92%
VACC 11.36%
VALN 12.99%
VAXX -10.53%
VBIV 3.44%
VBLT -8.77%
VCEL 2.64%
VCNX -0.49%
VCYT 1.77%
VERA -2.79%
VERU 9.04%
VERV -0.19%
VIGL 0.52%
VINC -1.38%
VIR 0.22%
VIRI -1.85%
VIRX -5.63%
VKTX -1.18%
VLON -13.04%
VNDA -2.29%
VOR 4.20%
VRCA -4.56%
VRDN 5.09%
VRNA 4.60%
VRPX -4.95%
VRTX 1.33%
VSTM -1.90%
VTGN -3.58%
VTVT 0.00%
VTYX -0.80%
VXRT 5.82%
VYGR -0.43%
VYNE -4.95%
VYNT 7.78%
WINT 7.90%
WVE -0.76%
XBIO -5.83%
XBIT -12.02%
XCUR -3.35%
XENE -0.21%
XERS 0.00%
XFOR 0.00%
XLO 2.47%
XLRN 0.00%
XNCR 1.46%
XOMA 5.64%
XOMAO -0.20%
XOMAP -0.76%
XRTX -2.38%
YMAB 0.83%
ZGNX 0.00%
ZIOP -0.88%
ZLAB 0.97%
ZNTL -3.16%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2023-09-09 Perkins Adelene Q Buy 768 133 Common Stock
2023-09-12 Perkins Adelene Q Sell 410 196 Common Stock
2023-09-09 Perkins Adelene Q Sell 768 133 Restricted Stock Unit
2022-08-02 Peluso Stephane Buy 14 994 Common Stock
2022-08-02 Peluso Stephane Sell 50 000 Restricted Stock Unit
INSIDER POWER
-20.55
Last 96 transactions
Buy: 10 433 668 | Sell: 9 549 867

Wolumen Korelacja

Długi: 0.01 (neutral)
Krótki: 0.15 (neutral)
Signal:(27.787) Neutral

Infinity Pharmaceuticals Korelacja

10 Najbardziej pozytywne korelacje
CHNA0.856
10 Najbardziej negatywne korelacje
HPLT-0.889

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Infinity Pharmaceuticals Korelacja - Waluta/Towar

The country flag 0.91
( very strong )
The country flag 0.01
( neutral )
The country flag 0.00
( neutral )
The country flag 0.91
( very strong )
The country flag 0.95
( very strong )
The country flag -0.63
( weak negative )

Infinity Pharmaceuticals Finanse

Annual 2022
Przychody: $2.59M
Zysk brutto: $1.03M (39.72 %)
EPS: $-0.480
FY 2022
Przychody: $2.59M
Zysk brutto: $1.03M (39.72 %)
EPS: $-0.480
FY 2021
Przychody: $1.86M
Zysk brutto: $738 000 (39.72 %)
EPS: $-0.530
FY 2020
Przychody: $1.72M
Zysk brutto: $682 000 (39.67 %)
EPS: $-0.680

Financial Reports:

No articles found.

Infinity Pharmaceuticals Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Infinity Pharmaceuticals

Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the treatment of solid tumors. The company has strategic alliances with Intellikine, Inc. to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K; Verastem, Inc. to research, develop, commercialize, and manufacture duvelisib and products containing duvelisib; and PellePharm, Inc. to develop and commercialize rights to its hedgehog inhibitor program, IPI-926, a clinical-stage product candidate, as well as collaboration agreements with Arcus Biosciences, Inc., F. Hoffmann-La Roche Ltd., and Bristol Myers Squibb Company. Infinity Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in Cambridge, Massachusetts.

O Sygnały na żywo

Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.

Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej

Total Execution Time: 1.8501019477844 seconds
Number of API calls: 3
Number of DB calls: 9